Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content and showing only the site header and footer.
    Difference
    0.5%
    Check dated 2026-09-27T20:39:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study page is replaced with a 403 Forbidden error, preventing access to the study record content and associated navigation. This indicates that access to the study information is currently restricted.
    Difference
    20%
    Check dated 2026-09-20T20:33:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision v3.6.6 has been released, replacing the previous v3.6.5. This appears to be a routine backend update that does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T20:52:39.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page revision label now reads v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-09T09:17:56.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Updated the page revision tag from v3.6.3 to v3.6.4, indicating an internal site update. The change represents maintenance or enhancements to the underlying platform rather than to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T23:05:49.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a software version update of the page rather than a change to trial content.
    Difference
    0.1%
    Check dated 2026-07-04T13:23:37.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.